The Research & Development team at ShouTi drives innovation in drug discovery and development targeting GPCR-related diseases. Comprising experts in biology, chemistry, preclinical development, and regulatory affairs, the team collaboratively advances projects from initial research through to clinical evaluation, ensuring effective and safe therapeutic solutions. Their multi-disciplinary approach integrates cutting-edge techniques and regulatory expertise to bring novel treatments to market efficiently.
Belen Carrillo-Rivas
Senior Vice President, Head Of...
Blai Coll
Chief Medical Officer
Fang Zhang
EVP & Head, Biology
Hui Lei
SVP, Chemistry
Huibin Yue
Vice President, Head Of Biomet...
Kanak Singh
Vice President, Program Manage...
Marc Navre
SVP & Head, Biology, ShouTi Ba...
Qinghua Meng
Senior Director Of Chemistry
Xichen Lin
Chief Scientific Officer & Gen...
Xinglong Jiang
SVP, Preclinical Development
View all